Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) EBIT per Share : ¥0.18 (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Tianjin Chase Sun Pharmaceutical Co EBIT per Share?

Tianjin Chase Sun Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.18.

During the past 12 months, the average EBIT per Share Growth Rate of Tianjin Chase Sun Pharmaceutical Co was -29.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -7.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 3.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tianjin Chase Sun Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SZSE:300026' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -7.9 Med: 16.1 Max: 84.2
Current: -7.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tianjin Chase Sun Pharmaceutical Co was 84.20% per year. The lowest was -7.90% per year. And the median was 16.10% per year.

SZSE:300026's 3-Year EBIT Growth Rate is ranked worse than
73.33% of 866 companies
in the Drug Manufacturers industry
Industry Median: 7.25 vs SZSE:300026: -7.90

Tianjin Chase Sun Pharmaceutical Co's EBIT for the three months ended in Mar. 2024 was ¥92 Mil.

Tianjin Chase Sun Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Tianjin Chase Sun Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Chase Sun Pharmaceutical Co EBIT per Share Chart

Tianjin Chase Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.17

0.24

0.30

0.26

0.22

Tianjin Chase Sun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.08	0.07	0.06	0.01	0.03

Tianjin Chase Sun Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tianjin Chase Sun Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	668.397	/	2980.185
=	0.22

Tianjin Chase Sun Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	92.146	/	2906.044
=	0.03

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.18

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tianjin Chase Sun Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 20, Quanfa Road, Tianjin Wuqing Development Area, Tianjin, CHN, 301700

Website

http://www.chasesun.cn

Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.

Executives

Yao Xiao Qing	Director
Chen Rui Qiang	Executives
Li Chun Xu	Executives
Lan Wu Jun	Directors, Directors, and Executives
Zheng Dan	Directors, executives
Zhang Kun	Executives
Gao Guo Wei	Executives
Shang Xiao Mei	Securities Affairs Representative
Sun Zhang Hai	Director
Wu Guang Ning	Supervisors
Wang Long	Executives
Liu Qiang	Supervisors
Ceng Guo Zhuang	Director
Su Bing Jun	Directors, executives
Nie Wei	Supervisors

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Headlines

No Headlines